Skip to main content

Antiphospholipid antibody syndrome presenting as transverse myelitis

Abstract

The antiphospholipid syndrome (APS) is characterized by arterial and/or venous thrombosis and pregnancy morbidity in the presence of anticardiolipin antibodies and/or lupus anticoagulant. APS can occur either as a primary disorder or secondary to a connective tissue disease, most frequently systemic lupus erythematosus. Central nervous system involvement is one of the most prominent clinical manifestations of APS, and includes arterial and venous thrombotic events, psychiatric features, and a variety of other nonthrombotic neurological syndromes. Although the mechanism of neurological involvement in patients with APS is thought to be thrombotic in origin and endothelial dysfunction associated with antiphospholipid antibodies. APS presenting as acute transverse myelitis is very rarely seen with a prevalence rate of 1%. We are describing a foreigner female presenting as acute transverse myelitis which on evaluation proved to be APS induced. So far, very few cases have been reported in literature with APS as etiology.

References

  1. Sherer Y, Hassin S, Shoenfeld Y, Levy Y, Livneh A, Ohry A, Langevitz P. Transverse myelitis in patients with antiphospholipid antibodies – the importance of early diagnosis and treatment. Clin Rheumatol 2002; 21:207–210.

    Article  CAS  Google Scholar 

  2. Carter D, Olchovsky D, Yonath H, Langevitz P, Ezra D. Simultaneous deep vein thrombosis and transverse myelitis with negative serology as a first sign of antiphospholipid syndrome: a case report and review of the literature. Clin Rheumatol 2006; 25:756–758.

    Article  Google Scholar 

  3. Kincaid O, Lipton HL. Viral myelitis: an update. Curr Neurol Neurosci Rep 2006; 6:469–474.

    Article  Google Scholar 

  4. Calgüneri M, Onat AM, Ozturk MA, Ozçakar L, Ureten K, Akdogan A, et al. Transverse myelitis in a patient with Behcet’s disease: favorable outcome with a combination of interferon-alpha. Clin Rheumatol 2005; 24:64–66.

    Article  Google Scholar 

  5. Moskau S, Urbach H, Hartmann A, Schmidt S. Multifocal myelitis in Behçet’s disease. Neurology 2003; 60:517.

    Article  Google Scholar 

  6. Theodoridou A, Settas L. Demyelination in rheumatic diseases. J Neurol Neurosurg Psychiatry 2006; 77:290–295.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol 2004; 56: 715–719.

    Article  CAS  Google Scholar 

  8. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346:752–763.

    Article  CAS  Google Scholar 

  9. Tristano AG. Autoimmune diseases associated with transverse myelitis. Review. Invest Clin 2009; 50:251–270.

    PubMed  Google Scholar 

  10. Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 2002; 46:1019–1027.

    Article  Google Scholar 

  11. Kim JH, Lee SI, Park SI, Yoo WH. Recurrent transverse myelitis in primary antiphospholipid syndrome – case report and literature review. Rheumatol Int 2004; 24:244–246.

    Article  CAS  Google Scholar 

  12. Berman M, Feldman S, Alter M, Zilber N, Kahana E. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981; 31:966–971.

    Article  CAS  Google Scholar 

  13. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis. Retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events. Arch Neurol 1993; 50:532–535.

    Article  CAS  Google Scholar 

  14. Klein NP, Ray P, Carpenter D, Hansen J, Lewis E, Fireman B, et al. Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies. Vaccine 2010; 28:1062–1068.

    Article  Google Scholar 

  15. Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun Rev 2010; 9:A395–A399.

    Article  Google Scholar 

  16. Sá MJ. Acute transverse myelitis: a practical reappraisal. Autoimmun Rev 2009; 9:128–131.

    Article  Google Scholar 

  17. Debette S, de Sèze J, Pruvo JP, Zephir H, Pasquier F, Leys D, Vermersch P. Long-term outcome of acute and subacute myelopathies. J Neurol 2009; 256:980–988.

    Article  CAS  Google Scholar 

  18. Schmalstieg WF, Weinshenker BG. Approach to acute or subacute myelopathy. Neurology 2010; 75(Suppl 1):S2–S8.

    Article  Google Scholar 

  19. Jacob A, Weinshenker BG. An approach to the diagnosis of acute transverse myelitis. Semin Neurol 2008; 28:105–120.

    Article  Google Scholar 

  20. Levine SR, Deegan MJ, Futrell N, Welch KM. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases. Neurology 1990; 40:1181–1189.

    Article  CAS  Google Scholar 

  21. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, Derue G, Hughes GR. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985; 44:281–283.

    Article  CAS  Google Scholar 

  22. Oosting JD, Derksen RH, Blokzijl L, Sixma JJ, de Groot PG. Antiphospholipid antibody positive sera enhance endothelial cell procoagulant activity – studies in a thrombosis model. Thromb Haemost 1992; 68:278–284.

    Article  CAS  Google Scholar 

  23. Chan KF, Boey ML. Transverse myelopathy in SLE: clinical features and functional outcomes. Lupus 1996; 5:294–299.

    Article  CAS  Google Scholar 

  24. Altrocchi PH. Acute transverse myelopathy. Arch Neurol 1963; 9:111– 119.

    Article  CAS  Google Scholar 

  25. Misra UK, Kalita J, Kumar S. A clinical MRI and neurophysiological study of acute transverse myelitis. J Neurol Sci 1996; 138:150–156.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Javvid M. Dandroo MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dandroo, J.M., Mohsin, N. & Nabi, F. Antiphospholipid antibody syndrome presenting as transverse myelitis. Egypt Rheumatol Rehabil 42, 204–206 (2015). https://doi.org/10.4103/1110-161X.168209

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-161X.168209

Keywords